Marquis Klemp

Adjuvant Nivolumab Boosts Survival Outcomes in Muscle-Invasive Bladder Cancer

February 17, 2025

You don't have permission to access "http://www.medpagetoday.com/meetingcoverage/mgucs/114247" on this server. Reference #18.b6e5c417.1739861723.35d6fbb6 https://errors.edgesuite.net/18.b6e5c417.1739861723.35d6fbb6 Read More

Marquis Klemp

Adjuvant Nivolumab Boosts Survival Outcomes in Muscle-Invasive Bladder Cancer

Novo’s Weight Loss Drugs Removed from FDA Shortage List

‘Active recovery’ after exercise is supposed to improve performance—but does it really work?

The Surprising Source of Next-Gen Antibiotics: Oyster Blood

New GLP-1 Data Reinforce CV Benefit

Tool Predicts Whether One Bruise in Pediatric ED Signals Abuse

Basilea is awarded additional CARB-X funding to develop new drug candidate from a novel class of antibiotics

FDA Updates ‘Healthy’ Claim for Foods — but Use Is Voluntary

How Cell Therapies Help Fight Solid Tumors

AI Catches Missing MRI Lesions

FDA Approves Second Generic Daily GLP-1 Drug for T2D

Novo’s Weight Loss Drugs Removed from FDA Shortage List

‘Active recovery’ after exercise is supposed to improve performance—but does it really work?

The Surprising Source of Next-Gen Antibiotics: Oyster Blood

New GLP-1 Data Reinforce CV Benefit

Tool Predicts Whether One Bruise in Pediatric ED Signals Abuse

About PhaMed

Recent News

You may have missed

About PhaMed

Recent News

Categories